Gemcitabine Combined With Mistletoe in Treating Patients With Advanced Solid Tumors
Stopped early · Phase 1
Conditions studied: Breast Cancer, Colorectal Cancer, Lung Cancer, Pancreatic Cancer
In brief
RATIONALE: Drugs used in chemotherapy, such as gemcitabine, use different ways to stop tumor cells from dividing so they stop growing or die. Mistletoe may slow the growth of tumor cells and may be an effective treatment for solid tumors. PURPOSE: Phase I trial to study the effectiveness of combining gemcitabine with mistletoe in treating patients who have advanced solid tumors.
Key facts
- Study ID
- NCT00049608
- Run by
- National Center for Complementary and Integrative Health (NCCIH)
- People needed
- 51
- Starts
- 2002-07-01
- Expected to finish
- 2011-08-01
- Last updated by the study team
- 2013-06-19
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office — Bethesda, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.